In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Magnesium Hydroxide powder Drug Master File in Korea (Magnesium Hydroxide powder KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Magnesium Hydroxide powder. The MFDS reviews the Magnesium Hydroxide powder KDMF as part of the drug registration process and uses the information provided in the Magnesium Hydroxide powder KDMF to evaluate the safety and efficacy of the drug.
After submitting a Magnesium Hydroxide powder KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Magnesium Hydroxide powder API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Magnesium Hydroxide powder suppliers with KDMF on PharmaCompass.